SCHEMBL9998535

SCHEMBL9998535

CCCC(=Cc1ccc(Cl)cc1)C(OC(C)=O)OC(C)=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.41
TRPA1 O75762 1/20 0.41
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
HDAC9 Q9UKV0 1/20 0.40
HDAC5 Q9UQL6 1/20 0.40
NOS3 P29474 2/20 0.40
NOS1 P29475 2/20 0.40
NOS2 P35228 2/20 0.40
MAOB P27338 1/20 0.38
MAPT P10636 2/20 0.38
GRIK1 P39086 1/20 0.38
KDM4E B2RXH2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9998533 1.00 CYP2C9 (0.41) CYP2C9TRPA1HDAC3HDAC4HDAC1
SCHEMBL9998505 0.88 ALDH1A1 (0.46) CYP2C9MAPTKDM4EALDH1A1CYP3A4
SCHEMBL9997810 0.88 CYP2C9 (0.43) CYP2C9TRPA1HDAC3HDAC4HDAC1
SCHEMBL9997808 0.88 CYP2C9 (0.43) CYP2C9TRPA1HDAC3HDAC4HDAC1
SCHEMBL9998268 0.87 MAOB (0.39) MAOBMAPTKDM4EALDH1A1MEN1
SCHEMBL9998270 0.87 MAOB (0.39) MAOBMAPTKDM4EALDH1A1MEN1
SCHEMBL9997624 0.87 MAPT (0.38) CYP2C9TRPA1MAOBMAPTKDM4E
SCHEMBL9997621 0.87 MAPT (0.38) CYP2C9TRPA1MAOBMAPTKDM4E
SCHEMBL9998017 0.85 TRPA1 (0.48) CYP2C9TRPA1NOS3NOS1NOS2
SCHEMBL9997805 0.85 LMNA (0.47) CYP2C9TRPA1MAOBMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 CYP2C9 28/4885TRPA1 1040/4885HDAC3 1408/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.